Efficacy and Safety of ddEC-ddP for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

Conditions:   HER2-negative Breast Cancer;   Neoadjuvant Chemotherapy Interventions:   Drug: Epirubicin;   Drug: Cyclophosphamid;   Drug: Docetaxel;   Drug: Paclitaxel Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials